Simultaneous Determination of Pravastatin and Its Main Metabolite, 3' α - Isopravastatin in Human Plasma by HPLC - MS

DENG Ming,LIU Hui-chen,XUE Hong-yuan,LIU Jian-fang
2005-01-01
Abstract:Objective: To establish an HPLC-MS method for simultaneous determination of pravastatin and its main metabolite, 3' α-isopravastatin in human plasma and to study their pharmacokinetics in healthy volunteers. Methods: After addition of mycophenolic acid (internal standard, IS) , the analytes in plasma samples were extracted with solid-phase extraction,then separated on a Discovery C_(18)(5μm,150 mm×4.6 mm) column with a mobile phase of methanol-acetonitrile-6 mmol·L~(-1) ammonium acetate solution (20: 30: 50) at a flow rate of 0.4 mL ·min~(-1). HPLC-ESI ~(-)-MS was performed in the selected ion monitoring (SIM) mode using target ions at m/z 423.4 (pravastatin and 3 'α-isopravastatin) and m/z 319.2 (IS) . Results:The blank plasma did not interfere with the determination of the analytes. The linear concentration ranges of the calibration curves for pravastatin and 3'α-isopravastatin were both 1.25-200 ng·mL~(-1). The limits of quantitation of pravastatin and 3'α-isopravastatin were both 1.25 ng·mL~(-1). The extraction recovery was more than 80% . Within-day RSD and between-day USD were less than 10%. Conclusion: The method is sensitive, accurate, and suitable for the pharmacokinetic study of pravastatin and its main metabolite,3'α-isopravastatin.
What problem does this paper attempt to address?